RB.L - Reckitt Benckiser Group plc

LSE - LSE Delayed price. Currency in GBp
6,790.00
-67.00 (-0.98%)
At close: 4:59PM BST
Stock chart is not supported by your current browser
Previous close6,857.00
Open6,840.00
Bid6,770.00 x 20000
Ask6,804.00 x 3500
Day's range6,768.00 - 6,879.67
52-week range6,496.00 - 8,110.43
Volume2,958,771
Avg. volume1,362,558
Market cap47.77B
Beta0.76
PE ratio (TTM)26.67
EPS (TTM)254.6
Earnings dateN/A
Forward Dividend & Yield1.71 (1.83%)
Ex-dividend date2017-08-17
1y target est7,974.76
  • The Wall Street Journal5 hours ago

    Today's Top Supply Chain and Logistics News From WSJ

    Delivering up-to-the minute news, analysis, interviews and explanatory journalism on logistics, supply-chain management, e-commerce and more

  • The Wall Street Journal12 hours ago

    [$$] Reckitt Makeover Clears Way for Pfizer Bid

    The London-listed consumer group is doing what activist Nelson Peltz wants Procter & Gamble to do—but M&A may be an ulterior motive.

  • The Wall Street Journal12 hours ago

    [$$] Maker of Lysol, Durex Splits Business in Bid to Boost Growth

    The U.K.’s Reckitt Benckiser said it would divide operations into two parts, consumer health and home/hygiene, as it and other consumer-goods giants scramble to jump-start sales.

  • Reutersyesterday

    FTSE rises to record close, blue-chips shrug off Reckitt blip

    British mid-caps jumped to a record closing level on Wednesday as investors grew more comfortable with the smaller, more domestically-focused stocks, while the FTSE 100 held its ground as third quarter earnings trickled in. The FTSE 250 (.FTMC) was up 0.6 percent on the day, closing at a record 20,263.1 points. Mid-caps have strongly outperformed the bigger index this year, up around 12 percent against the FTSE 100's 6 percent rise.

  • Reckitt to reshape as sales growth evaporates
    Reutersyesterday

    Reckitt to reshape as sales growth evaporates

    Britain's Reckitt Benckiser will split its business into two divisions -- consumer healthcare and home and hygiene products -- to try to revive sales that are set to stall this year. It hopes to improve performance in its newly expanded health business, while bringing greater focus and accountability to its slower-growth home and hygiene business. Reckitt, whose products range from Durex condoms to Lysol disinfectant, has blamed fallout from a cyber attack, a failed product launch and a safety scandal in South Korea for its lacklustre sales.

  • Reuters - UK Focusyesterday

    Reckitt to reshape as sales growth evaporates

    LONDON, Oct (Shenzhen: 000069.SZ - news) 18 (Reuters) - Britain's Reckitt Benckiser (Xetra: A0M1W6 - news) will split its business into two divisions -- consumer healthcare and home and hygiene products -- to try to revive sales that are set to stall this year. It hopes to improve performance in its newly expanded health business, while bringing greater focus and accountability to its slower-growth home and hygiene business. Reckitt, whose products range from Durex condoms to Lysol disinfectant, has blamed fallout from a cyber attack, a failed product launch and a safety scandal in South Korea for its lacklustre sales.

  • Pfizer's Advil May Be Just the Thing for Sickly Reckitt
    Bloombergyesterday

    Pfizer's Advil May Be Just the Thing for Sickly Reckitt

    The problem is getting shareholders to back a cash call to pay for it.

  • Fool.co.ukyesterday

    1 FTSE 100 growth stock I’d hold for 25 years alongside Unilever plc

    Unilever plc (LSE: ULVR) isn’t the only growing FTSE 100 (INDEXFTSE: UKX) business I’d hold for the long haul.

  • Reuters - UK Focusyesterday

    FTSE 100 shrugs off Reckitt Benckiser blip

    The UK's top share index held its ground on Wednesday as third quarter earnings trickled in, with shares in Reckitt Benckiser dipping after a disappointing update. Britain's blue chip FTSE 100 index was ...

  • Reutersyesterday

    European shares rise as third-quarter earnings roll in, Catalonia weighs on IBEX

    European shares opened slightly higher on Wednesday as a flurry of fresh third-quarter results came in, though politics kept Spanish equities in negative territory. The pan-European STOXX 600 (.STOXX) index was up 0.2 percent with all sectors trading in positive territory. After opening in line with other bourses, Madrid's IBEX (IBEX) eased back with a 0.3 percent slide.

  • Reuters - UK Focusyesterday

    European shares rise as Q3 earnings roll in

    European shares opened slightly higher on Wednesday as a flurry of fresh third-quarter results came in, though politics kept Spanish equities in negative territory. By 0712 GMT, the pan-European STOXX ...

  • Reutersyesterday

    Reckitt Benckiser to form two business units for better focus

    Reckitt Benckiser (RB.L) plans to reorganise its business into two distinct units, one for health and the other for hygiene and home products, as it tries to improve its flagging performance. The maker of Durex condoms, Nurofen tablets and Dettol cleaners announced the restructuring on Wednesday, along with its third-quarter sales figures. The British company made the decision to restructure after its June acquisition of U.S. baby formula maker Mead Johnson, which will account for roughly half of the larger health unit's sales.

  • Reuters - UK Focusyesterday

    Reckitt cuts full-year outlook after Q3 sales fall

    LONDON, Oct (Shenzhen: 000069.SZ - news) 18 (Reuters) - Reckitt Benckiser (Xetra: A0M1W6 - news) cut its full-year sales forecast on Wednesday after another decline in quarterly sales, as the British consumer goods maker continues to struggle with fallout from a cyber attack, a failed product launch and a safety scandal in South Korea. Reckitt said third-quarter sales were 3.21 billion pounds ($4.23 billion), down 1 percent on a like-for-like basis.

  • Reckitt CEO Focuses on Health, Looking Beyond Worst Year
    Bloombergyesterday

    Reckitt CEO Focuses on Health, Looking Beyond Worst Year

    Reckitt Benckiser Group Plc separated its home-care and health businesses, sharpening its focus on brands such as Durex condoms and Enfamil baby formula after a second cut in the sales forecast this year....

  • Reuters - UK Focusyesterday

    Reckitt Benckiser to form two business units for better focus

    LONDON, Oct (Shenzhen: 000069.SZ - news) 18 (Reuters) - Reckitt Benckiser (Xetra: A0M1W6 - news) plans to reorganise its business into two distinct units, one for health and the other for hygiene and home products, as it tries to improve its flagging performance. The British company made the decision to restructure after its June acquisition of U.S. baby formula maker Mead Johnson, which will account for roughly half of the larger health unit's sales. "Here is the perfect opportunity for us to be able to create a proper leader in consumer health with the expertise and the focus that is needed to drive true leadership ... while at the same time unleash the potential of our hygiene/home portfolio by providing focus and accountability," Chief Executive Rakesh Kapoor told Reuters.

  • Reuters - UK Focus2 days ago

    China's appetite for baby food gives Danone a growth spurt

    PARIS, Oct (Shenzhen: 000069.SZ - news) 17 (Reuters) - Danone (LSE: 0KFX.L - news) 's sales of baby milk formula in China rose strongly in the third quarter, beating forecasts and sending the French food company's shares to a record high. Danone published its strong sales figures as Le Monde reported that chairman Franck Riboud, 61, is to stand down and hand over to chief executive Emmanuel Faber, 53, who will become both chairman and CEO.

  • Forbes8 days ago

    3 FTSE 100 Stocks To Buy And Hold For The Next Decade

    On the hunt for blue chips with exceptional earnings profiles? Then step this way and look at the three profits powerhouses I have identified from Britain's FTSE 100 index.

  • Reuters9 days ago

    FTSE on the defensive as stronger pound drags

    (This October 9 story corrects to remove reference to Magellan Asset Management short position on Tesco. Magellan has a 3.41 percent stake in Tesco) By Helen Reid LONDON (Reuters) - Britain's major share ...

  • Reuters10 days ago

    FTSE on the defensive as stronger pound drags

    Britain's main share index fell behind European rivals on Monday in response to a rise in sterling which hit companies that earn money in dollars such as the mining and energy sectors. The FTSE 100 (.FTSE) fell 0.2 percent to 7,507.89 points, with the biggest dollar-earning stocks, miners and oil majors, the worst-performing as sterling gained against the U.S. currency. Weakness in sterling had helped the index to produce its strongest week in 10 months last week but the pound's bounce from lows after the weekend put pressure on the index, which has a big international exposure.

  • Fool.co.uk11 days ago

    2 FTSE 100 stocks that could make you incredibly rich

    The FTSE 100 (INDEXFTSE: UKX) is packed with shares that could help build a fortune. Royston Wild looks at a couple that could open the door to brilliant riches.

  • Fool.co.uk19 days ago

    Why I see more upside ahead for Unilever plc

    Shares in Unilever plc (LON:ULVR) may have more to give following a strong start to the year.

  • Fool.co.uk22 days ago

    Why I bought this beaten-up growth stock instead of Reckitt Benckiser Group plc

    Reckitt Benckiser Group plc (LON: RB) might seem attractive after recent declined but I prefer this small-cap.

  • Reuters - UK Focuslast month

    Reckitt Benckiser chairman to retire in 2018

    Reckitt Benckiser Group Chairman Adrian Bellamy will retire at its annual general meeting after 14 years in the post, the British consumer goods maker said on Tuesday. Christopher Sinclair, who has served on the board since 2015, will take on the role of non-executive chairman at that time, the company said. Sinclair, who has worked at PepsiCo (NYSE: PEP - news) , is currently executive chairman of the board at toymaker Mattel Inc (NasdaqGS: MAT - news) .

  • Reuters - UK Focuslast month

    Indivior files lawsuits against Suboxone generic rivals

    Indivior (Frankfurt: 2IVA.F - news) 's U.S. subsidiary has filed lawsuits against firms seeking approval for generic versions of its opioid addiction treatment Suboxone, which generates 80 percent of the drugmaker's revenue. The patent lawsuits were filed against Dr. Reddy's , Allergan Plc (Frankfurt: A1W5NE - news) 's Actavis Laboratories, Endo International's Par Pharmaceutical, Alvogen Pharma US, Teva Pharmaceutical Industries and Mylan NV.

  • Reuters - UK Focuslast month

    Germany's Merck considers sale of consumer health business

    FRANKFURT/COLOGNE, Sept 5 (Reuters) - Germany's Merck KGaA (LSE: 0O14.L - news) is considering selling its consumer healthcare business which has sales of $1 billion a year to help fund more research into prescription drugs and amid declines in the company's separate liquid crystal business. The company said on Tuesday that to remain competitive the consumer healthcare business would need further investment and therefore it was considering a sale or strategic partnership instead, adding that a review process was at an early stage with a final decision expected to be made early next year. Fully anticipating this, we are preparing strategic options," Belen Garijo, chief executive of Merck's entire Healthcare (Shanghai: 603313.SS - news) division, said in a statement.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes